NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
June 8, 2004 • Volume 1 / Number 23 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

NCI Cancer Bulletin Archive

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.


NCAB Quarterly Meeting
The National Cancer Advisory Board (NCAB) held its quarterly meeting June 2-3 on the NIH campus in Bethesda, Md. NCAB advises the HHS Secretary and the NCI Director with respect to the institute's activities, including reviewing and recommending for support grants and cooperative agreements following technical and scientific peer review.

In addition to hearing the NCI Director's report, the President's Cancer Panel (PCP) Report, and other NCI reports and plans, NCAB and PCP members recognized the late Dr. Paul Calabresi by announcing an award in his honor (see note below).

NCAB membership consists of leading representatives of the health and scientific disciplines; the general public, including leaders in fields of public policy, law, health policy, economics, and management; and experts in environmental carcinogenesis. In addition, there are 12 nonvoting members from various federal agencies.

Award Named for Calabresi
At its June 2 meeting, NCAB announced the creation of the Paul Calabresi Award for Clinical Oncology in memory of Dr. Calabresi's contributions to cancer research. The award's purpose is to increase the number of physicians and basic scientists who are trained to perform patient-oriented oncology research; to design, test, participate in, and manage clinical protocols; and to work together to accelerate the translation of research to delivery. As a K-12 award, it will support career development programs in institutes with the capability to train investigators who will focus on translational therapeutic research.

Dr. Calabresi, who died of cancer in October 2003, was a pioneer in the pharmacological treatment of cancer and early translational research. He is remembered for his dedication to patients, his mentorship of young clinicians, his development of the clinical oncology field, and his service to NCI as a member of the PCP and chair of the NCAB. Dr. Calabresi also served on the steering committee for the National Dialogue on Cancer and the National Cancer Legislation Advisory Committee, through which he participated in the strategic development of the Nation's War on Cancer.

Science Writer Seminar Postponed
Due to the National Day of Mourning in honor of President Reagan, the science writer's seminar scheduled for June 11 has been postponed. The Bulletin will provide more details as they become available.

NCI Director Delivers Message of Hope to Cancer Survivors
NCI Director Dr. Andrew C. von Eschenbach delivered the keynote address at the annual National Cancer Survivor's Day Luncheon, sponsored by CanCare of Houston, Texas. In addition to highlighting recent advances in cancer survivorship research, Dr. von Eschenbach discussed his own battle with cancer, stressing the importance of emotional support during therapy.

The luncheon featured the ceremonial lighting of hundreds of votive candles in remembrance of those who have faced cancer. Founded in 1990, CanCare is an interfaith cancer support network made up of cancer survivors who provide free one-on-one, long-term emotional support to cancer patients and their families.

Cover of Evaluating Screening Performance in Practice Breast Cancer Surveillance Consortium Report Available
NCI's Breast Cancer Surveillance Consortium (BCSC) has released Evaluating Screening Performance in Practice, a report describing BCSC and its unique research contributions. The report provides an overview of BCSC's mission, history, and structure and also describes BCSC's current areas of research and other accomplishments to date. Findings from published studies and a discussion of the challenges that lie ahead for the Consortium are also included. The full report is available at

In the May 11 issue of the NCI Cancer Bulletin, the receipt dates for applications for PA-04-102 were incomplete; the dates shown referred only to revised applications. New applications may also be submitted by June 1, 2004; Oct. 1, 2004; Feb. 1, 2005; and June 1, 2005.